COPD

Genetic Risk for COPD Linked to Lower Lung Function from Childhood

A new study finds individuals with higher genetic risk for COPD show lower lung function starting in childhood.

COPD

Race-Neutral Spirometry Equations May Boost Black Patient Enrollment in COPD Trials

Eliminating racially adjusted spirometry results could lead to a significant increase in Black patient participation in COPD clinical trials, according to findings presented at ATS 2024.

COPD

Gabapentinoids May Cause Severe COPD Exacerbation

Researchers say the study supports warnings from regulatory agencies and highlights the importance of considering this potential risk when prescribing gabapentin and pregabalin to patients with COPD.

Dupixent Significantly Reduced COPD Exacerbations in Second Phase 3 Trial

by RT Staff | Nov 30, 2023 | COPD | 0

The second Dupixent investigational phase 3 COPD trial has shown that Dupixent reduced exacerbations by 34%, confirming positive published results from the phase 3 BOREAS trial.

WHO: Smoking Remains the Leading Cause of COPD

by RT Staff | Nov 15, 2023 | COPD, Smoking | 0

Smoking remains the leading cause of COPD, which kills an estimated 3 million people every year, according to the World Health Organization.

World COPD Day 2023 Emphasizes Early Detection

by RT Staff | Nov 15, 2023 | Association News, COPD, Education | 0

On November 15th, healthcare organizations across the globe are observing World COPD Day 2023 by emphasizing the importance of early disease detection.

11 States With the Highest COPD Rates

by RT Staff | Oct 25, 2023 | Association News, COPD, General Healthcare | 0

Eleven states have the highest COPD rates in the country, according to the American Lung Association’s COPD State Briefs, with one state’s prevalence rate reaching 13.6%.

Northwestern Medicine Completes First Endobronchial Valve Procedure

by RT Staff | Oct 23, 2023 | COPD, Therapy Devices, Thoracic Surgery | 0

Northwestern Medicine’s Palos Hospital recently conducted its first endobronchial valve procedure using Pulmonx’s Zephyr EBV system.

HCO Acquires Virtual Care Platform to Expand Respiratory Therapy Services

by RT Staff | Oct 11, 2023 | Asthma, COPD, Home Care, Insomnias | 0

Health Care Originals, a maker of cardiopulmonary wearable systems, acquired Dawn Health’s virtual sleep care platform to accelerate the deployment of its Nightingale virtual care to benefit Americans with asthma or COPD.

Suspected Bronchiectasis Tied to Higher Mortality, Even Without COPD

by RT Staff | Oct 5, 2023 | COPD, Diagnostics, Other Chronic Diseases, Tobacco | 0

A study of current and former smokers found that suspected bronchiectasis is associated with a heightened risk of all-cause mortality, even without the presence of COPD.

Depression Soared for Older COPD Adults During the Pandemic

by RT Staff | Oct 3, 2023 | COPD, General Healthcare | 0

Older adults with COPD had a heightened risk of depression during the early stages of the COVID-19 pandemic, according to a new longitudinal study.

COPD Hospitalizations Spike, Especially for Women and Younger People

by RT Staff | Oct 2, 2023 | COPD | 0

Annual hospital admissions for COPD in Canada increased 69% since 2002, especially in females and people under age 65, according to new research.

Transplanting COPD Patients’ Own Cells Restores Lung Function

by RT Staff | Sep 29, 2023 | COPD | 0

Researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease using the patients’ own lung cells.

Partnership to Improve Pulmonary Rehab Reach for COPD

by RT Staff | Sep 5, 2023 | COPD, Pulmonary Rehab | 0

The COPD Foundation and Kivo Health, which provides telehealth pulmonary rehabilitation for individuals with COPD, have partnered to improve access to virtual pulmonary rehab.

Pharmacological Treatment of Respiratory Disorders

by RT Staff | Sep 1, 2023 | Asthma, COPD, US Pharmaceuticals | 0

In this 2023 update of RT’s pharmacological treatment of respiratory disorders, the most commonly administered classes of pulmonary medications are reviewed.

Category: COPD

COPD

COPD

COPD